10.1002/ejoc.202000116
European Journal of Organic Chemistry
FULL PAPER
N-(2,2-Dimethyl-4,5-dioxohexan-3-yl)acrylamide
(3e),
Typical
cm-1; HRMS: m/z [M + Na]+ calcd. for C15H19NO4Na: 300.1212; found:
procedure 2: β-Ketoenamide 1e (160 mg, 0.514 mmol) and trifluoroacetic
acid (5 mL) were heated to 80 °C in a sealed tube for 15 min. After cooling
to room temperature, water was slowly added and the resulting mixture
was extracted 2–3 times with dichloromethane. The combined organic
layers were dried with Na2SO4, filtered and concentrated. Purification by
column chromatography (SiO2, hexanes/EtOAc 40%) provided 79 mg
(73%) of 1,2 diketone 3e as pale yellow oil. 1H NMR (400 MHz, CDCl3): δ
= 0.94 (s, 9 H, tBu), 2.32 (s, 3 H, Me), 5.25 (d, J = 7.6 Hz, 1 H, CH), 5.64
300.1233.
(E)-N-(2,3-Dioxo-1-phenylbutyl)but-2-enamide (3j) and compound 5j:
According to typical procedure 2, enamide 1j (430 mg, 1.25 mmol) in
trifluoroacetic acid (5 mL) gave 91 mg (30%) of 1,2-diketone 3j as pale
yellow oil and 84 mg (30%) of compound 5j as pale yellow solid. Data for
3j: 1H NMR (400 MHz, CDCl3): δ = 1.82–1.84 (m, 3 H, =CHMe), 2.28 (s, 3
H, COMe), 5.83–5.87 (m, 1 H, =CHCO), 6.21 (d, J = 5.6 Hz, 1 H, CH), 6.46
(sbr, 1 H, NH), 6.79–6.88 (m, 1 H, =CHMe), 7.29–7.34 (m, 5 H, Ph) ppm;
13C NMR (100 MHz, CDCl3): δ = 17.8 (q, Me), 24.3 (q, 3´-Me), 57.5 (d, C-
1), 123.8, 128.5, 128.9, 129.3, 134.0, 141.7 (5 d, s, C-2´, C-3´, Ph), 165.5
(s, C-1´), 192.8, 196.1 (2 s, C-2, C-3) ppm; IR (neat): = 3305 (NH), 3020–
2835 (=C-H, C-H), 1700, 1675 (C=O), 1640–1505 (C=C) cm-1; HRMS: m/z
[M + Na]+ calcd. for C14H15NO3Na: 268.0950; found: 268.0986. Data for
dimer 5j: M. p. > 220 °C; 1H NMR ( 400 MHz, CDCl3): δ = 1.41 (s, 6 H, Me),
1.88 (d, J = 6.8 Hz, 6 H, Me), 6.00 (d, J = 15.2 Hz, 2 H, =CH), 6.87–6.96
(m, 2 H, =CH), 7.27–7.37 (m, 6 H, Ar), 7.69 (d, J = 7.2 Hz, 2 H, Ar), 8.19
(sbr, 2 H, NH) ppm; 13C NMR (100 MHz, CDCl3): δ = 9.5 (q, Me), 17.9 (q,
Me), 57.1 (s, C-1), 72.2 (s, C-3), 122.3, 124.4, 124.7, 129.2, 129.6, 137.9,
139.0, 142.1 (6 d, 2 s, C-2´, C-3´, Ar), 167.2 (s, C-1´), 199.2 (s, C-2) ppm;
IR (KBr): = 3355 (NH), 3020–2875 (=C-H, C-H), 1775, 1680 (C=O),
1640–1505 (C=C) cm-1; HRMS: m/z [M + Na]+ calcd. for C28H27N2O4Na:
477.1868; found: 477.1829.
(dd, J = 9.2, 1.6 Hz, 1 H, =CH2), 6.10–6.27 (m, 3 H, =CH2, NH) ppm; 13
C
NMR (100 MHz, CDCl3): δ = 23. 4 (q, Me), 26.7, 35.0 (q, s, tBu), 58.1 (d,
C-1), 127.6, 129.8 (d, t, C-2´, C-3´), 165.5 (s, C-1´), 196.3, 198.1 (2 s,
C-2, C-3) ppm; IR (neat): = 3300 (NH), 2960–2855 (=C-H, C-H), 1710–
1660 (C=O), 1620–1530 (C=C) cm-1; HRMS: m/z [M + Na]+ calcd. for
C11H17NO3Na: 234.1101; found: 234.1105.
(E)-N-(2,2-Dimethyl-4,5-dioxohexan-3-yl)but-2-enamide
(3f):
According to typical procedure 2, β-ketoenamide enamide 1f (225 mg,
0.69 mmol), in trifluoroacetic acid (5 mL) gave 124 mg (80%) of 1,2-
diketone 3f as pale yellow solid. M. p. 73–76 °C; 1H NMR (400 MHz,
CDCl3): δ = 0.93 (s, 9 H, tBu), 1.79–1.81 (m, 3 H, Me), 2.31 (s, 3 H, Me),
5.17 (d, J = 7.4 Hz, 1 H, CH), 5.81–5.85 (dd, J = 15.2, 1.1 Hz, 1 H, =CH),
6.11–6.18 (m, 1 H, NH), 6.74–6.83 (m, 1 H, =CH); 13C NMR (100 MHz,
CDCl3): δ = 17.8 (q, C-4), 23.5 (q, Me), 26.7, 34.8 (q, s, tBu), 58.1 (d,
C-1), 124.0, 141.3 (2 d, C-2´, C-3´), 165.9 (s, C-1´), 196.4, 198.1 (2 s,
C-2, C-3) ppm; IR (KBr): = 3285 (NH), 2960–2865 (=CH, C-H), 1720–
1670 (C=O), 1605–1520 (C=C) cm-1; HRMS: m/z [M + Na]+ calcd. for
C12H19NO3Na: 248.1263; found: 248.1224; C12H19NO5 (225.1): calcd. C,
63.98; H, 6.50; N, 6.22; found: C, 64.48; H, 6.66; N, 5.76.
N-(2,3-Dioxo-1-phenylbutyl)cinnamamide (3k) and Compound 5k:
According to typical procedure 2, enamide 1k (80 mg, 0.196 mmol) in
trifluoroacetic acid (2 mL) gave 19 mg (33%) of 1,2-diketone 3k and 14 mg
(25%) of compound 5k as pale yellow oils. Data for 3k: 1H NMR (400 MHz,
CDCl3): δ = 2.31 (s, 3 H, Me), 6.33 (d, J = 5.8 Hz, 1 H, CH), 6.46 (d, J =
15.6 Hz, 1 H, =CH), 6.63 (sbr, 1 H, NH), 7.25–7.49 (m, 10 H, Ph), 7.62 (d,
J = 15.6 Hz, 1 H, =CH) ppm; 13C NMR (100 MHz, CDCl3): δ = 24.4 (q, Me),
57.7 (d, C-1), 128.0, 128.4, 128.9, 129.0, 129.4, 130.0, 130.7, 133.9, 134.5,
142.5 (8 d, 2 s, C-2´, C-3´, Ph), 165.5 (s, C-1´), 192.8, 196.0 (2 s, C-2,
C-3) ppm; IR (neat): = 3405 (NH), 3020 (=C-H, C-H), 1705, 1675 (C=O),
1620 (C=C) cm-1; HRMS: m/z [M + Na]+ calcd. for C19H17NO3Na: 330.1106;
found: 330.1156. Data for compound 5k: 1H NMR (400 MHz, CDCl3): δ =
1.46 (s, 6 H, Me), 6.62 (d, J = 15.5 Hz, 2 H, =CH), 7.31–7.37, 7.54–7.56
(2 m, 14 H, 4 H, Ar, Ph), 7.72 (d, J = 15.6 Hz, 2 H, =CH), 8.44 (sbr, 2 H,
NH) ppm; 13C NMR (100 MHz, CDCl3): δ = 9.6 (q, Me), 57.2 (s, C-1), 72.5
(s, C3), 120.1, 122.4, 124.5, 128.2, 128.9, 129.4, 129.7, 130.1, 134.5,
137.9, 139.1, 142.9 (9 d, 3 s, C-2´, C-3´, Ar, Ph), 167.3 (s, C-1´), 199.8 (s,
C-2) ppm; IR (KBr): = 3340 (NH), 3070–2980 (=C-H, C-H), 1780, 1665
(C=O), 1625-1510 (C=C) cm-1; HRMS: m/z [M + H]+ calcd. for C38H31N2O4:
579.2278; found: 579.2296.
N-(2,2-Dimethyl-4,5-dioxohexan-3-yl)cinnamamide (3g): According to
typical procedure 2, β-ketoenamide 1g (300 mg, 0.775 mmol) in
trifluoroacetic acid (5 mL) gave 133 mg (60%) of 1,2-diketone 3g as pale
yellow solid. M. p. 75–78 °C; 1H NMR (400 MHz, CDCl3): δ = 0.99 (s, 9 H,
tBu), 2.36 (s, 3 H, Me), 5.34 (d, J = 7.4 Hz, 1 H, CH), 6.34 (dbr, J = 4.9 Hz,
1 H, NH), 6.47 (dd, J = 15.6, 1.0 Hz, 1 H, =CH), 7.33–7.35, 7.46–7.49 (2
m, 3 H, 2 H, Ph), 7.60 (d, J = 15.6 Hz, 1 H, =CH) ppm; 13C NMR (100 MHz,
CDCl3): δ = 23.5 (q, Me), 26.8, 35.1 (q, s, tBu), 58.3 (d, C-1), 119.3, 128.0,
128.9, 130.0, 134.5, 142.5 (5 d, s, C-2´, C-3´, Ph), 166.2 (s, C-1´), 196.4,
198.1 (2 s, C-2, C-3) ppm; IR (KBr): = 3305 (NH), 2955–2875 (=C-H,
C-H), 1705–1685 (C=O), 1630 C=C) cm-1; HRMS: m/z [M + Na]+ calcd. for
C17H21NO3Na: 310.1414; found: 310.1422.
(E)-N-(2,2-Dimethyl-4,5-dioxohexan-3-yl)-3-(4-nitrophenyl)acrylamide
(3h): According to typical procedure 2, enamide 1h (200 mg, 0.69 mmol)
in trifluoroacetic acid (4 mL) gave 84 mg (55%) of 1,2-diketone 3h as pale
yellow solid. M. p. 132–134 °C; 1H NMR (500 MHz, CDCl3): δ = 0.99 ( s, 9
H, tBu), 2.36 (s, 3 H, Me), 5.35 (d, J = 7.6 Hz, 1 H, CH), 6.28 (dbr, J = 7.6
Hz, 1 H, NH), 6.37 (d, J = 15.5 Hz, 1 H, =CH), 7.49–7.62 (m, 3 H, Ar),
7.97–8.01 (m, 2 H, =CH, Ar) ppm; 13C NMR (125 MHz, CDCl3): δ = 23.5
(q, Me), 26.8, 35.1 (q, s, tBu), 58.3 (d, C-1), 124.8, 124.9, 129.2, 130.0,
130.9, 133.4, 137.4, 148.3 (6 d, 2 s, C-2´, C-3´, Ar), 164.8 (s, C-1´), 196.3,
198.1 (2 s, C-2, C-3) ppm; IR (KBr): = 3295 (NH), 2965–2875 (=C-H,
C-H), 1710–1655 (C=O), 1615–1580 (C=C) cm-1; HRMS: m/z [M + Na]+
calcd. for C17H20N2O5Na: 355.1270; found: 355.1268.
Oxazole 2l and compound 5l: According to typical procedure 2, enamide
1l (75 mg, 0.219 mmol) in trifluoroacetic acid (2 mL) gave 6.5 mg (15%) of
oxazole 2l as a colorless solid and 5 mg (12%) of compound 5l as a pale
yellow oil. Data for oxazole 2l:[21] 1H NMR (500 MHz, CDCl3): δ = 2.51,
2.65 (2 s, 3 H each, Me), 7.44–7.48, 8.13-8.15 (2 m, 3 H, 2 H, Ph) ppm.
HRMS: m/z [M + H]+ calcd. for C16H12NO2: 202.0863; found: 202.0866.
Data for compound 5l: 1H NMR (500 MHz, CDCl3): δ = 1.41, 2.14 (2 s, 6 H
each, Me), 7.27–7.38, 7.67–7.69 (2 m, 6 H, 2 H, Ar), 8.05 (sbr, 2 H, NH)
ppm; 13C NMR (125 MHz, CDCl3): δ = 9.5, 23.8 (2 q, Me), 57.1 (s, C-1),
72.1 (s, C-3), 122.5, 124.4, 129.3, 129.7, 137.8, 139.1 (4 d, 2 s, Ar), 171.9
(s, C-1´), 199.9 (s, C-2) ppm; IR (neat): = 3340 (NH), 3070–2980 (=C-H,
(E)-N-(2,2-Dimethyl-4,5-dioxohexan-3-yl)-3-(furan-2-yl)acrylamide
(3i): According to typical procedure 2, enamide 1i (50 mg, 0.13 mmol), in
trifluoroacetic acid (3 mL) gave 25 mg (70%) of 1,2-diketone 3i as pale
yellow oil. 1H NMR (400 MHz, CDCl3): δ = 0.97 (s, 9 H, tBu), 2.35 (s, 3 H,
MeCO), 5.33 (d, J = 7.4 Hz, 1 H, CH), 6.35 (d, J = 15.3 Hz, 1 H, =CH),
6.41–6.43 (m, 1 H, Furyl), 6.54 (d, J = 3.3 Hz, 1 H, Furyl), 7.35 (d, J = 15.3
Hz, 1 H, =CH), 7.41 (d, J = 3.1 Hz, 1 H, Furyl); 13C NMR (100 MHz, CDCl3):
δ = 23.5 (q, Me), 26.7, 35.1 (q, s, tBu), 58.3 (d, C-1), 112.3, 114.6 (2 d,
C-H), 1780, 1665 (C=O) cm-1; HRMS: m/z [M
C24H22N2O4Na: 425.1472; found: 425.1463.
+
Na]+ calcd. for
N-[2,2-Dimethyl-1-(3-methylquinoxalin-2-yl)propyl]acrylamide (6e),
Typical Procedure 3: 1,2-diketone 3e (66 mg, 0.31 mmol), o-
phenylenediamine (41 mg, 0.37 mmol), cerium(IV) ammonium nitrate (17
mg, 0.03 mmol) and water (2.5 mL) were stirred for 1 h at room
temperature. The mixture was quenched with ethyl acetate (2 mL) and
washed three times with water. The organic phase was dried with Na2SO4
and concentrated to dryness. The product was purified by column
chromatography (SiO2, hexanes/EtOAc 10%) furnishing 6e (45 mg, 51%)
C-3Furyl, C-4Furyl), 116.9, 128.9, 144.4, 151.0 (3 d, s, C-2´, C-3´, C-2Furyl
,
C-5Furyl), 166.2 (s, C-1´), 196.3, 198.0 (2 s, C-2, C-3) ppm; IR (neat): =
3250 (NH), 2965–2880 (=CH, C-H), 1710–1660 (C=O), 1620–1530 (C=C)
9
This article is protected by copyright. All rights reserved.